These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34958021)

  • 1. Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer's Disease: A Case Series.
    Dhaynaut M; Sprugnoli G; Cappon D; Macone J; Sanchez JS; Normandin MD; Guehl NJ; Koch G; Paciorek R; Connor A; Press D; Johnson K; Pascual-Leone A; El Fakhri G; Santarnecchi E
    J Alzheimers Dis; 2022; 85(4):1667-1676. PubMed ID: 34958021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home-based transcranial alternating current stimulation (tACS) in Alzheimer's disease: rationale and study design.
    Altomare D; Benussi A; Cantoni V; Premi E; Rivolta J; Cupidi C; Martorana A; Santarnecchi E; Padovani A; Koch G; Borroni B
    Alzheimers Res Ther; 2023 Sep; 15(1):155. PubMed ID: 37715232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.
    Buckley RF; Mormino EC; Rabin JS; Hohman TJ; Landau S; Hanseeuw BJ; Jacobs HIL; Papp KV; Amariglio RE; Properzi MJ; Schultz AP; Kirn D; Scott MR; Hedden T; Farrell M; Price J; Chhatwal J; Rentz DM; Villemagne VL; Johnson KA; Sperling RA
    JAMA Neurol; 2019 May; 76(5):542-551. PubMed ID: 30715078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medial Temporal Lobe Tau Aggregation Relates to Divergent Cognitive and Emotional Empathy Abilities in Alzheimer's Disease.
    Chow TE; Veziris CR; Mundada N; Martinez-Arroyo AI; Kramer JH; Miller BL; Rosen HJ; Gorno-Tempini ML; Rankin KP; Seeley WW; Rabinovici GD; La Joie R; Sturm VE
    J Alzheimers Dis; 2023; 96(1):313-328. PubMed ID: 37742643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Ferrari-Souza JP; Lussier FZ; Leffa DT; Therriault J; Tissot C; Bellaver B; Ferreira PCL; Malpetti M; Wang YT; Povala G; Benedet AL; Ashton NJ; Chamoun M; Servaes S; Bezgin G; Kang MS; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; O'Brien JT; Rowe JB; Cohen AD; Lopez OL; Tudorascu DL; Karikari TK; Klunk WE; Villemagne VL; Soucy JP; Gauthier S; Souza DO; Zetterberg H; Blennow K; Zimmer ER; Rosa-Neto P; Pascoal TA
    Sci Adv; 2023 Apr; 9(14):eade1474. PubMed ID: 37018391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in gamma frequency oscillations correlate with cortical tau deposition in Alzheimer's disease.
    Nencha U; Rigoni I; Ribaldi F; Altomare D; Seeck M; Garibotto V; Vulliémoz S; Frisoni GB
    Neurobiol Aging; 2024 Jul; 139():1-4. PubMed ID: 38574424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model.
    Rossano SM; Johnson AS; Smith A; Ziaggi G; Roetman A; Guzman D; Okafor A; Klein J; Tomljanovic Z; Stern Y; Brickman AM; Lee S; Kreisl WC; Lao P
    Alzheimers Dement; 2024 Apr; 20(4):2397-2407. PubMed ID: 38298155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
    Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
    JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
    Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
    J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
    Li WW; Shen YY; Tian DY; Bu XL; Zeng F; Liu YH; Chen Y; Yao XQ; Li HY; Chen DW; Zhou FY; Yang H; Li QM; Bao WQ; Guan YH; Zhou HD; Jin RB; Wang YJ
    J Alzheimers Dis; 2019; 69(1):169-178. PubMed ID: 30958377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults.
    Chen X; Cassady KE; Adams JN; Harrison TM; Baker SL; Jagust WJ
    J Neurosci; 2021 Jan; 41(2):366-375. PubMed ID: 33219003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.
    Sepulcre J; Grothe MJ; Sabuncu M; Chhatwal J; Schultz AP; Hanseeuw B; El Fakhri G; Sperling R; Johnson KA
    JAMA Neurol; 2017 Jul; 74(7):813-820. PubMed ID: 28558094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity.
    Huijbers W; Schultz AP; Papp KV; LaPoint MR; Hanseeuw B; Chhatwal JP; Hedden T; Johnson KA; Sperling RA
    J Neurosci; 2019 Jan; 39(3):548-556. PubMed ID: 30482786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of multisession 40Hz tACS on hippocampal perfusion in patients with Alzheimer's disease.
    Sprugnoli G; Munsch F; Cappon D; Paciorek R; Macone J; Connor A; El Fakhri G; Salvador R; Ruffini G; Donohoe K; Shafi MM; Press D; Alsop DC; Pascual Leone A; Santarnecchi E
    Alzheimers Res Ther; 2021 Dec; 13(1):203. PubMed ID: 34930421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.